Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences

On August 21, 2024 Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, immuno-oncology and beyond, reported that it will be participating in the following upcoming investor conferences (Press release, Replicate Bioscience, AUG 21, 2024, View Source [SID1234646040]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 22nd Annual Global Healthcare Conference in New York, N.Y.
Dates: September 4-6, 2024
Fireside chat to be held Friday, September 6 at 10:45 a.m. EDT
Replicate participants: Nathaniel Wang, Ph.D., CEO; Rachael Lester, CBO

Cantor Global Healthcare Conference in New York, N.Y.
Dates: September 17-19, 2024
Replicate participants: Nathaniel Wang, Ph.D., CEO; Rachael Lester, CBO
Replicate leadership will also present at the following upcoming scientific meetings:

RNA Leaders USA Congress in San Diego, Calif.
Keynote panel title: Scaling RNA Therapies to Deliver on the Promise of Precision Medicine
Presenter: Nathaniel Wang, Ph.D., CEO
Date and time: Wednesday, September 4, 2024 at 9:55 a.m. PDT

Presentation title: Next-Generation Self-Replicating RNA Drives Major Improvements to Clinical Bioactivity while Retaining a Strong Safety Profile
Presenter: Nathaniel Wang, Ph.D., CEO
Date and time: Wednesday, September 4, 2024 at 4:25 p.m. PDT

3rd Non-Viral RNA Delivery Systems Summit in Boston, Mass.
Presentation title: LNP & Polymer Delivery of Self-Replicating RNA: Unlocking the Potential of Low Dose RNA Vaccines & Gene Therapy
Presenter: Andy Geall, Ph.D., CDO
Date and time: Thursday, October 3, 2024 at 9:30 a.m. EDT